Exane Derivatives’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,299
| Closed | -$2.38K | – | 765 |
|
|
2022
Q1 | $2.38K | Sell |
1,299
-27,049
| -95% | -$49.5K | ﹤0.01% | 737 |
|
|
2021
Q4 | $40K | Buy |
+28,348
| New | +$40K | 0.01% | 520 |
|
|
2021
Q1 | – | Sell |
-1,517
| Closed | -$2.96K | – | 865 |
|
|
2020
Q4 | $2.96K | Hold |
1,517
| – | – | ﹤0.01% | 579 |
|
|
2020
Q3 | $3.63K | Sell |
1,517
-27,036
| -95% | -$64.6K | ﹤0.01% | 501 |
|
|
2020
Q2 | $83.7K | Buy |
+28,553
| New | +$83.7K | 0.02% | 299 |
|